Clinical Trial Update: Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel [Phase 2]

View source ↗

Summary

Phase 2 trial comparing DBI-001 Gel to aqueous gel in atopic dermatitis was terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• DBI-001 Gel (DBI-001 Gel)

Snippet

Sponsor: DermBiont, Inc. | Conditions: Atopic Dermatitis | Phase 2 | Status: TERMINATED | Results posted: 2023-11-08